Partex
PrivateLast Round
Series C
Apr 25, 2019
Total Funding Raised
$3M
Company Overview
Partex is a biotechnology company that develops an advanced artificial intelligence and blockchain technology platform designed to support all stages of drug development from pipeline to market.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Biotechnology, ML Platforms, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS, Marketplace Commission, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Partex Comps
Public and private peers based on sector, stage, and business model.
Partex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 25, 2019 | ||||
| Pre Seed | Dec 22, 2016 |
Partex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Block.one | Series C |
| HCS Beteiligungsgesellschaft | Pre Seed |
| FinLab EOS VC Fund | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 7, 2025
Monthly visitors grew 95% MoM, reaching 6.7K.
- Apr 25, 2019
Led by ATAI Life Sciences and FinLab EOS VC Fund.
Partex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Partex's valuation, stock price, and market status.
